MOTS-C MOTS-C activates AMPK, improving cellular energy efficiency, glucose uptake, and fatty-acid oxidation
What Results Can Patients Expect
Are recovering from surgery and want to accelerate the healing process
Clinical Trial Safety Data: Across multiple studies using oral and intravenous AOD-9604 for up to 24 weeks, the peptide demonstrated an excellent safety profile indistinguishable from placebo
Prescription Required Neuroswift Inj Composition: Each 1 ml
By Emily Rodriguez, RDN, CSSD|Source reviewed by FormBlends Editorial Standards Team|| Source Reviewed Written by Emily Rodriguez, RDN, CSSD Checked against primary sources by FormBlends Editorial Standards Team In This Article This article is part of our Peptide Therapy collection